Throne: Whoop Co-Founder's New Venture Brings Computer Vision to the Commode

The Consumer Electronics Show is no stranger to novel technologies, but Throne, a new device from Whoop co-founder John Capodilupo, is turning heads—and raising eyebrows. Unveiled at CES 2026, Throne utilizes computer vision to analyze human excrement, promising insights into gut health and overall well-being. The device, which attaches to the side of a standard toilet bowl, is currently available for pre-order at $340, with a $6 monthly membership fee to access the data.

A Throne for Data: How It Works

Throne's hardware is equipped with a camera and microphone, designed to track bowel movements and urination patterns. Capodilupo emphasizes the importance of establishing a baseline for each user. "The hardware is designed to understand what your base state is to be able to identify when you fall out of that pattern," he stated. This baseline allows the device to detect deviations in frequency, texture, size, and volume, potentially flagging early warning signs of digestive issues. The company believes that individuals on medications like GLP-1s will be especially interested in the device. The company has not released how it will handle Personally Identifiable Information (PII) or health data in compliance with HIPAA regulations.

Powering the device is a long-life battery. A single charge is expected to last for up to a month. And for those concerned about constantly unplugging it, Throne ships with a 13-foot USB-C cable, ensuring easy access to power outlets.

Market Implications and Analyst Perspective

While the concept may seem unconventional, the market for personalized health monitoring is booming. Consumers are increasingly willing to invest in devices that provide detailed insights into their physiological data. Whether Throne can successfully navigate the privacy concerns and prove its clinical efficacy remains to be seen. However, the involvement of a seasoned entrepreneur like Capodilupo lends credibility to the venture. The market cap for companies in the smart home healthcare space is currently $45 billion. Analysts predict a further 12% increase in the next fiscal year.

The $6 per month membership fee will be a crucial element to watch. A recurring revenue model will be key to Throne’s long-term financial viability. The challenge will be demonstrating sufficient value to justify the ongoing cost. Ultimately, Throne's success hinges on its ability to translate raw data into actionable insights that improve user health outcomes. Early adopters will likely be those already deeply invested in tracking their biometrics. Mainstream adoption will require rigorous validation and clear communication of the device's benefits. From a market perspective, the stool analysis sector may be niche, but the potential upside is substantial. The P/E ratio for companies in the health-tech space is currently hovering around 25, reflecting investor optimism. Whether Throne can carve out a significant share of this market remains to be seen, but its debut at CES has certainly sparked a conversation.